Your browser doesn't support javascript.
loading
Entinostat combined with Fludarabine synergistically enhances the induction of apoptosis in TP53 mutated CLL cells via the HDAC1/HO-1 pathway.
Zhou, Zhen; Fang, Qin; Li, Peifan; Ma, Dan; Zhe, Nana; Ren, Mei; Chen, Bingqing; He, Zhengchang; Wang, Jun; Zhong, Qin; Wang, Jishi.
Afiliação
  • Zhou Z; Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China; Department of Pharmacy, Affiliated Baiyun Hospital of Guizhou Medical University, Guiyang 550004, China; Key Laboratory of Hematological Disease Diagnostic and Treat Centre of Guizhou Province, Guiyan
  • Fang Q; Department of Pharmacy, Affiliated Baiyun Hospital of Guizhou Medical University, Guiyang 550004, China; Department of Pharmacy, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China.
  • Li P; Clinical Research Centre, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China.
  • Ma D; Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China; Key Laboratory of Hematological Disease Diagnostic and Treat Centre of Guizhou Province, Guiyang 550004, China; Department of Hematology, Guizhou Provincial Laboratory of Hematopoietic Stem Cell Trans
  • Zhe N; Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China; Key Laboratory of Hematological Disease Diagnostic and Treat Centre of Guizhou Province, Guiyang 550004, China; Department of Hematology, Guizhou Provincial Laboratory of Hematopoietic Stem Cell Trans
  • Ren M; Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China; Key Laboratory of Hematological Disease Diagnostic and Treat Centre of Guizhou Province, Guiyang 550004, China; Department of Hematology, Guizhou Provincial Laboratory of Hematopoietic Stem Cell Trans
  • Chen B; Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China; Key Laboratory of Hematological Disease Diagnostic and Treat Centre of Guizhou Province, Guiyang 550004, China; Department of Hematology, Guizhou Provincial Laboratory of Hematopoietic Stem Cell Trans
  • He Z; Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China; Key Laboratory of Hematological Disease Diagnostic and Treat Centre of Guizhou Province, Guiyang 550004, China.
  • Wang J; Clinical Research Centre, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China.
  • Zhong Q; Clinical Research Centre, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China.
  • Wang J; Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China; Key Laboratory of Hematological Disease Diagnostic and Treat Centre of Guizhou Province, Guiyang 550004, China; Department of Hematology, Guizhou Provincial Laboratory of Hematopoietic Stem Cell Trans
Life Sci ; 232: 116583, 2019 Sep 01.
Article em En | MEDLINE | ID: mdl-31226417
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Vidarabina / Benzamidas / Leucemia Linfocítica Crônica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / Proteína Supressora de Tumor p53 / Heme Oxigenase-1 / Histona Desacetilase 1 Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Aged80 Idioma: En Revista: Life Sci Ano de publicação: 2019 Tipo de documento: Article País de publicação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Vidarabina / Benzamidas / Leucemia Linfocítica Crônica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / Proteína Supressora de Tumor p53 / Heme Oxigenase-1 / Histona Desacetilase 1 Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Aged80 Idioma: En Revista: Life Sci Ano de publicação: 2019 Tipo de documento: Article País de publicação: Holanda